Cargando…
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833832/ https://www.ncbi.nlm.nih.gov/pubmed/36640796 http://dx.doi.org/10.1016/S1473-3099(22)00834-9 |
| _version_ | 1784868326398230528 |
|---|---|
| author | Marking, Ulrika Bladh, Oscar Havervall, Sebastian Svensson, Julia Greilert-Norin, Nina Aguilera, Katherina Kihlgren, Martha Salomonsson, Ann-Cristin Månsson, Maja Gallini, Radiosa Kriegholm, Cecilia Bacchus, Philip Hober, Sophia Gordon, Max Blom, Kim Smed-Sörensen, Anna Åberg, Mikael Klingström, Jonas Thålin, Charlotte |
| author_facet | Marking, Ulrika Bladh, Oscar Havervall, Sebastian Svensson, Julia Greilert-Norin, Nina Aguilera, Katherina Kihlgren, Martha Salomonsson, Ann-Cristin Månsson, Maja Gallini, Radiosa Kriegholm, Cecilia Bacchus, Philip Hober, Sophia Gordon, Max Blom, Kim Smed-Sörensen, Anna Åberg, Mikael Klingström, Jonas Thålin, Charlotte |
| author_sort | Marking, Ulrika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9833832 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98338322023-01-12 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection Marking, Ulrika Bladh, Oscar Havervall, Sebastian Svensson, Julia Greilert-Norin, Nina Aguilera, Katherina Kihlgren, Martha Salomonsson, Ann-Cristin Månsson, Maja Gallini, Radiosa Kriegholm, Cecilia Bacchus, Philip Hober, Sophia Gordon, Max Blom, Kim Smed-Sörensen, Anna Åberg, Mikael Klingström, Jonas Thålin, Charlotte Lancet Infect Dis Correspondence Elsevier Ltd. 2023-02 2023-01-11 /pmc/articles/PMC9833832/ /pubmed/36640796 http://dx.doi.org/10.1016/S1473-3099(22)00834-9 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Marking, Ulrika Bladh, Oscar Havervall, Sebastian Svensson, Julia Greilert-Norin, Nina Aguilera, Katherina Kihlgren, Martha Salomonsson, Ann-Cristin Månsson, Maja Gallini, Radiosa Kriegholm, Cecilia Bacchus, Philip Hober, Sophia Gordon, Max Blom, Kim Smed-Sörensen, Anna Åberg, Mikael Klingström, Jonas Thålin, Charlotte 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection |
| title | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection |
| title_full | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection |
| title_fullStr | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection |
| title_full_unstemmed | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection |
| title_short | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection |
| title_sort | 7-month duration of sars-cov-2 mucosal immunoglobulin-a responses and protection |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833832/ https://www.ncbi.nlm.nih.gov/pubmed/36640796 http://dx.doi.org/10.1016/S1473-3099(22)00834-9 |
| work_keys_str_mv | AT markingulrika 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT bladhoscar 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT havervallsebastian 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT svenssonjulia 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT greilertnorinnina 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT aguilerakatherina 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT kihlgrenmartha 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT salomonssonanncristin 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT manssonmaja 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT galliniradiosa 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT kriegholmcecilia 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT bacchusphilip 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT hobersophia 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT gordonmax 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT blomkim 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT smedsorensenanna 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT abergmikael 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT klingstromjonas 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection AT thalincharlotte 7monthdurationofsarscov2mucosalimmunoglobulinaresponsesandprotection |